Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844857 · ClinicalTrials.gov registry record · Phase 4
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 291
- Enrollment target
NCT00844857 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 291 participants.
The verdict
NCT00844857, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 291 participants
- Enrollment target
Study Summary
The main goal of this study is to help answer the following research question(s) and not to treat the child's illness. * Can this study drug make children with bipolar depression feel better? * Does this study drug work better than a placebo (sugar pill)? * Does this study drug cause side effects in children who take it? * Is this drug safe to use in children? (The study drug is a mixture of olanzapine and fluoxetine)
Interventions
- DRUG Placebo
- DRUG Olanzapine Fluoxetine Combination (OFC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00844857
The ClinicalTrials.gov registry entry for NCT00844857 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00844857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00844857 about?
NCT00844857 is a clinical study titled "A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression". The main goal of this study is to help answer the following research question(s) and not to treat the child's illness. * Can this study drug make children with bipolar depression feel better? * Does this study drug work better than a placebo (sugar pill)? * Does this study drug cause side effects i...
What is the current status of trial NCT00844857?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 291 participants. The study started on 2009-04. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00844857?
The interventions under investigation include: Placebo (DRUG), Olanzapine Fluoxetine Combination (OFC) (DRUG).
Who is sponsoring clinical trial NCT00844857?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.